Investment Summary

Greer Capital Advisors Invests In Discovery Biomed

On November 1, 2007, private equity firm Greer Capital Advisors invested in life science company Discovery Biomed

Investment Highlights
  • This is Greer Capital Advisors’ 5th transaction in the Life Science sector.
  • This is Greer Capital Advisors’ 7th transaction in the United States.
  • This is Greer Capital Advisors’ 4th transaction in Alabama.
Investment Fate
  • Discovery Biomed was sold to a strategic buyer in 2022.

Investment Summary

Date 2007-11-01
Target Discovery Biomed
Sector Life Science
Investor(s) Greer Capital Advisors
Deal Type Venture

Target

Discovery Biomed

Birmingham, Alabama, United States
Discovery Biomed is an operator of boutique biotechnology company seeks to contribute to improvements in human health through its expertise, work, and facilities by providing partners and clients with pilot screening and high-throughput screening (HTS) services for therapeutic-related bioassays, providing partners and clients with custom immortalized cell lines, and performing therapeutics discovery for certain failure-to-secrete diseases in humans. Discovery Biomed was founded in 2007 and is based in Birmingham, Alabama.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Greer Capital Advisors

Mountain Brook, Alabama, United States

Investor


Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.


DEAL STATS #
Overall 7 of 8
Sector: Life Science M&A 5 of 6
Type: Venture M&A Deals 6 of 7
State: Alabama M&A 4 of 5
Country: United States M&A 7 of 8
Year: 2007 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-24 Cumberland Pharmaceuticals

Nashville, Tennessee, United States

Cumberland Pharmaceuticals is a pharmaceutical company that acquires and develops branded prescription products primarily in the gastroenterology, critical care and infection control areas. Cumberland Pharmaceuticals was founded in 1999 and is based in Nashville, Tennessee.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-18 CardioSpectra

San Antonio, Texas, United States

CardioSpectra, Inc. is a medical device company committed to developing novel solutions for worldwide healthcare problems through the implementation of its expertise in optical imaging, interventional cardiology, medical devices, and materials science.

Sell $25M